CRLF2 and precursor B-cell acute lymphoblastic leukemia: We next assessed the potential leukemogenic cooperation between overexpressed Crlf2 and two distinct B-ALL-associated activating Jak2 point mutants (Jak2R683G or Jak2P933R) in vivo.